Literature DB >> 11733532

The HET-s prion protein of the filamentous fungus Podospora anserina aggregates in vitro into amyloid-like fibrils.

Suzana Dos Reis1, Bénédicte Coulary-Salin, Vincent Forge, Ioan Lascu, Joël Bégueret, Sven J Saupe.   

Abstract

The HET-s protein of Podospora anserina is a fungal prion. This protein behaves as an infectious cytoplasmic element that is transmitted horizontally from one strain to another. Under the prion form, the HET-s protein forms aggregates in vivo. The specificity of this prion model compared with the yeast prions resides in the fact that under the prion form HET-s causes a growth inhibition and cell death reaction when co-expressed with the HET-S protein from which it differs by 13 residues. Herein we describe the purification and initial characterization of recombinant HET-s protein expressed in Escherichia coli. The HET-s protein self-associates over time into high molecular weight aggregates. These aggregates greatly accelerate precipitation of the soluble form. HET-s aggregates appear as amyloid-like fibrils using electron microscopy. They bind Congo Red and show birefringence under polarized light. In the aggregated form, a HET-s fragment of approximately 7 kDa is resistant to proteinase K digestion. CD and FTIR analyses indicate that upon transition to the aggregated state, the HET-s protein undergoes a structural rearrangement characterized by an increase in antiparallel beta-sheet structure content. These results suggest that the [Het-s] prion element propagates in vivo as an infectious amyloid.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11733532     DOI: 10.1074/jbc.M110183200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Amyloid aggregates of the HET-s prion protein are infectious.

Authors:  Marie-Lise Maddelein; Suzana Dos Reis; Stéphane Duvezin-Caubet; Bénédicte Coulary-Salin; Sven J Saupe
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

Review 2.  Fatal attraction: nonself recognition and heterokaryon incompatibility in filamentous fungi.

Authors:  N Louise Glass; Isao Kaneko
Journal:  Eukaryot Cell       Date:  2003-02

3.  Het up mould unleashes a sporekiller prion.

Authors:  Durgadas P Kasbekar
Journal:  J Biosci       Date:  2003-12       Impact factor: 1.826

4.  Progress toward an ultimate proof of the prion hypothesis.

Authors:  Susan W Liebman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-01       Impact factor: 11.205

5.  Domain organization and structure-function relationship of the HET-s prion protein of Podospora anserina.

Authors:  Axelle Balguerie; Suzana Dos Reis; Christiane Ritter; Stéphane Chaignepain; Bénédicte Coulary-Salin; Vincent Forge; Katell Bathany; Ioan Lascu; Jean-Marie Schmitter; Roland Riek; Sven J Saupe
Journal:  EMBO J       Date:  2003-05-01       Impact factor: 11.598

6.  Localization of HET-S to the cell periphery, not to [Het-s] aggregates, is associated with [Het-s]-HET-S toxicity.

Authors:  Vidhu Mathur; Carolin Seuring; Roland Riek; Sven J Saupe; Susan W Liebman
Journal:  Mol Cell Biol       Date:  2011-10-28       Impact factor: 4.272

7.  Prion-like nanofibrils of small molecules (PriSM) selectively inhibit cancer cells by impeding cytoskeleton dynamics.

Authors:  Yi Kuang; Marcus J C Long; Jie Zhou; Junfeng Shi; Yuan Gao; Chen Xu; Lizbeth Hedstrom; Bing Xu
Journal:  J Biol Chem       Date:  2014-08-25       Impact factor: 5.157

8.  An unstructured region is required by GAV homologue for the fibrillization of host proteins.

Authors:  Li-Na Ji; Hai-Ning Du; Feng Zhang; Hong-Tao Li; Xiao-Ying Luo; Jun Hu; Hong-Yu Hu
Journal:  Protein J       Date:  2005-05       Impact factor: 2.371

Review 9.  Structural basis of infectious and non-infectious amyloids.

Authors:  Ulrich Baxa
Journal:  Curr Alzheimer Res       Date:  2008-06       Impact factor: 3.498

Review 10.  Prion propagation: the role of protein dynamics.

Authors:  John A Pezza; Tricia R Serio
Journal:  Prion       Date:  2007-01-10       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.